| scholarly article | Q13442814 |
| P2093 | author name string | Atman P Shah | |
| Mark J Russo | |||
| Elizabeth M Johnson | |||
| Valluvan Jeevanandam | |||
| Jaishankar Raman | |||
| Michael J Hur | |||
| Travis Siffring | |||
| P2860 | cites work | Long-term use of a left ventricular assist device for end-stage heart failure. | Q34109624 |
| Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure | Q34139611 | ||
| Natriuretic peptides and mortality after stroke | Q34407855 | ||
| Circulatory assist devices in heart failure patients | Q37332169 | ||
| Outcomes and predictors of early mortality after continuous-flow left ventricular assist device implantation as a bridge to transplantation. | Q37617047 | ||
| Patient selection for ventricular assist devices: a moving target | Q38071757 | ||
| Novel thrombosis risk index as predictor of left ventricular assist device thrombosis | Q39392199 | ||
| Mechanical unloading leads to echocardiographic, electrocardiographic, neurohormonal, and histologic recovery | Q40359611 | ||
| Pre-operative prediction of post-VAD implant mortality using easily accessible clinical parameters | Q43270906 | ||
| Predicting survival in patients receiving continuous flow left ventricular assist devices: the HeartMate II risk score. | Q44994074 | ||
| Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients | Q45086778 | ||
| Prognostic values of B-type natriuretic peptide in severe sepsis and septic shock | Q48255307 | ||
| Fifth INTERMACS annual report: risk factor analysis from more than 6,000 mechanical circulatory support patients. | Q48310222 | ||
| Decreased plasma concentration of brain natriuretic peptide as a potential indicator of cardiac recovery in patients supported by mechanical circulatory assist systems | Q48693996 | ||
| The time course of natriuretic hormones as plasma markers of myocardial recovery in heart transplant candidates during ventricular assist device support reveals differences among device types | Q48792385 | ||
| Prospective validation of the prognostic usefulness of B-type natriuretic peptide in asymptomatic patients with chronic severe aortic regurgitation. | Q48856321 | ||
| Elevated plasma brain natriuretic peptide levels independent of heart disease in acute ischemic stroke: correlation with stroke severity | Q48858329 | ||
| Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. | Q50954069 | ||
| Third INTERMACS Annual Report: the evolution of destination therapy in the United States. | Q51157053 | ||
| The Fourth INTERMACS Annual Report: 4,000 implants and counting. | Q51178030 | ||
| Right heart failure after left ventricular assist device implantation in patients with chronic congestive heart failure. | Q51291989 | ||
| Clinical outcomes in patients with chronic congestive heart failure who undergo left ventricular assist device implantation. | Q51328571 | ||
| The Registry of the International Society for Heart and Lung Transplantation: 29th official adult heart transplant report--2012. | Q53123820 | ||
| Time course of reverse remodeling of the left ventricle during support with a left ventricular assist device | Q57756336 | ||
| Patient selection for left ventricular assist devices | Q62770373 | ||
| Clinical outcomes for continuous-flow left ventricular assist device patients stratified by pre-operative INTERMACS classification | Q82942602 | ||
| INTERMACS profiles of advanced heart failure: the current picture | Q83948628 | ||
| Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted | Q84045094 | ||
| Late aortic insufficiency related to poor prognosis during left ventricular assist device support | Q84837394 | ||
| P433 | issue | 5 | |
| P921 | main subject | cardiac surgery | Q235007 |
| P304 | page(s) | e36-9 | |
| P577 | publication date | 2015-09-01 | |
| P1433 | published in | ASAIO Journal | Q15751141 |
| P1476 | title | Prophylactic Subclavian Artery Intraaortic Balloon Counter-Pulsation is Safe in High-Risk Cardiac Surgery Patients | |
| P478 | volume | 61 |
| Q52725319 | Altered regulation of cardiac ankyrin repeat protein in heart failure. |
| Q64267151 | Dynamics and prognostic value of B-type natriuretic peptide in left ventricular assist device recipients |
| Q36987869 | N-terminal pro B type natriuretic peptide in high cardiovascular-risk patients for noncardiac surgery: What is the current prognostic evidence? |
Search more.